Financial insights of KPHMW

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2024-06-30
Total revenue	-	0*	0	20
General and administrative	1,612.267	1,414*	1,443.827	1,537.973
Research and development	2,123.725	2,591*	2,729.891	906.68
Collaboration credits	1,233.224	2,091*	1,658.248	-
In-process r&d impairment	-	4,624*	0	-
Change in fair value of contingent consideration	7.427	3,911*	-1,721.033	120.234
Total operating expenses	2,510.195	10,448*	794.437	2,564.887
Operating loss	-2,510.195	-10,448*	-794.437	-2,544.887
Impairment of intangible assets	-	0*	-	-
Loss on disposal of fixed assets	-	0*	-	-
Interest income	-	273*	-	-
Interest expense	-	5*	-	-
Interest income, net	139.338	-	201.822	342.102
Other expense, net	-47.127	-89*	-23.708	-18.861
Total other income, net	92.212	179*	178.114	323.241
Loss before income tax provision	-2,417.984	-10,269*	-616.323	-
Income tax provision	0	647*	-643.129	-
Net loss	-2,417.984	-10,916	26.806	-2,221.646
Unrealized loss on marketable securities	-	-	-	-2.828
Foreign currency translation adjustments	-	-	-	21.467
Net loss attributable to common shareholders	-2,417.984	-	26.806	-
Comprehensive income (loss)	-	-	-	-2,203.007
Net loss attributable to common shareholders	-2,417.984	-10,916	26.806	-

Basic EPS	-0.58	-2.7	0.01	-0.53
Diluted EPS	-0.58	-2.838	0.01	-0.53
Basic Average Shares	4,174,802	4,043,531	4,289,853	4,170,627
Diluted Average Shares	4,174,802	3,846,006	4,361,740	4,170,627

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.